📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Potenza Therapeutics

1.1 - Company Overview

Potenza Therapeutics Logo

Potenza Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of preclinical-stage biotechnology oncology programs that utilize the body's own immune system to seek out, recognize, and destroy tumors through diverse mechanisms influencing tumor immunity; founded in 2014 and headquartered in Cambridge, Massachusetts.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Potenza Therapeutics

Coordination Pharma Logo

Coordination Pharma

HQ: United States Website
  • Description: Provider of nanoparticle-based anticancer therapies, including CPI-100, which delivers immunostimulatory chemotherapeutic combinations directly to tumors. Offers the NCP platform using nanoscale coordination polymers to develop products targeting solid tumors, and seeks partnership opportunities to enhance current cancer immunotherapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Coordination Pharma company profile →
Cartesian Therapeutics Logo

Cartesian Therapeutics

HQ: United States Website
  • Description: Provider of potent, safer cell therapy in and beyond oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cartesian Therapeutics company profile →
Complix Logo

Complix

HQ: Belgium Website
  • Description: Provider of Alphabody biopharmaceuticals focused on discovering and developing a novel class of therapeutics that bind with high affinity to disease targets. Offerings include Cell Penetrating Alphabodies to modulate intracellular protein interactions, a pipeline for intracellular targets in cancer, autoimmunity, and viral diseases, and anti-Covid-19 Alphabodies targeting SARS-CoV-2 fusion for prophylactic and therapeutic use.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Complix company profile →
OctreoPharm Sciences Logo

OctreoPharm Sciences

HQ: Germany Website
  • Description: Provider of radiopharmaceuticals and theranostic solutions for neuroendocrine tumors, including OPS201, a peptide for PRRT with 90Yttrium or 177Lutetium, and OPS202, a 68Gallium-labeled PET imaging agent targeting somatostatin receptors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OctreoPharm Sciences company profile →
Notable Logo

Notable

HQ: United States Website
  • Description: Provider of personalized drug combination testing for cancer patients and a Predictive Medicine Platform (PMP) that predicts patient response to specific therapies to identify responsive patients before treatment. Develops therapeutics, including Presponse Therapeutics and the PLK-1 inhibitor volasertib, with development guided by predictive patient response data.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Notable company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Potenza Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Potenza Therapeutics

2.2 - Growth funds investing in similar companies to Potenza Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Potenza Therapeutics

4.2 - Public trading comparable groups for Potenza Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Potenza Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Potenza Therapeutics

What does Potenza Therapeutics do?

Potenza Therapeutics is a provider of preclinical-stage biotechnology oncology programs that utilize the body's own immune system to seek out, recognize, and destroy tumors through diverse mechanisms influencing tumor immunity; founded in 2014 and headquartered in Cambridge, Massachusetts.

Who are Potenza Therapeutics's competitors?

Potenza Therapeutics's competitors and similar companies include Coordination Pharma, Cartesian Therapeutics, Complix, OctreoPharm Sciences, and Notable.

Where is Potenza Therapeutics headquartered?

Potenza Therapeutics is headquartered in United States.

How many employees does Potenza Therapeutics have?

Potenza Therapeutics has 1,000 employees 🔒.

When was Potenza Therapeutics founded?

Potenza Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Potenza Therapeutics in?

Potenza Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Potenza Therapeutics

Who are the top strategic acquirers in Potenza Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Potenza Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Potenza Therapeutics?

Top strategic M&A buyers groups and sectors for Potenza Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Potenza Therapeutics's sector and industry vertical

Which are the top PE firms investing in Potenza Therapeutics's sector and industry vertical?

Top PE firms investing in Potenza Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Potenza Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Potenza Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Potenza Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Potenza Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Potenza Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Potenza Therapeutics?

The key public trading comparables and valuation benchmarks for Potenza Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Potenza Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Potenza Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Potenza Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Potenza Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Potenza Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Potenza Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Potenza Therapeutics